Skip to content

Fenofibric Acid Acyl-β-D-Glucuronide

Fenofibric Acid Acyl-β-D-Glucuronide

Product Description
CAT No.
ALN-F012019
CAS No.
60318-63-0
Mol. F.
C23H23ClO10
Mol. Wt.
494.9
Stock
Please Inquire
RFQ
Chemical Name : (2S,3S,4S,5R,6S)-6-((2-(4-(4-Chlorobenzoyl)phenoxy)-2-methylpropanoyl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid
Smiles : O=C(C(C)(C)OC1=CC=C(C(C2=CC=C(Cl)C=C2)=O)C=C1)O[C@@H]([C@@H]([C@@H](O)[C@@H]3O)O)O[C@@H]3C(O)=O
Inchi : InChI=1S/C31H30N4O10/c1-14-10-11-19(12-15(14)2)35-28(40)22(16(3)34-35)33-32-21-9-5-8-20(23(21)36)17-6-4-7-18(13-17)30(43)45-31-26(39)24(37)25(38)27(44-31)29(41)42/h4-13,24-27,31-32,36-39H,1-3H3,(H,41,42)/b33-22-/t24-,25-,26+,27-,31-/m0/s1/i16+2

Fenofibrate raw materials: HPLC methods for assay and purity and an NMR method for purity

Pauline M. Lacroix a , Brian A. Dawson b,*, Roger W. Sears b , D. Bruce Black b , Terry D. Cyr b , Jean-Claude EthiernJournal of Pharmaceutical and Biomedical Analysis 18 (1998) 383u2013402

Development of continuous spherical crystallization to prepare fenofibrate agglomerates with impurity complexation using MSMPR crystallizer

, Roger W. Sears b , D. Bruce Black b , Terry D. Cyr b , Jean-Claude Ethier – Journal of Pharmaceutical and Biomedical Analysis 18 (1998) 383–402

Stability indicating UPLC method for simultaneous determination of atorvastatin, fenofibrate and their degradation products in tablets

Kohei Tahara, Yuichi Kono, Allan S. Myerson, and Hirofumi Takeuchi – Cryst. Growth Des. 2018, 18, 11, 6448–6454

Request For Quotation

Related Products